Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Timed Delivery of Paclitaxel/Carboplatin vs Temozolomide in Melanoma
NCT00568451Phase 2Terminated
- Sponsor
- Mayo Clinic
- Start
- Jun 2006
- Primary completion
- May 2009
- Modality
- DNA Intercalators/Alkylators, Cytokines & Interferons, Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of Paclitaxel Micelles for Injection, carboplatin in melanoma, sponsored by Mayo Clinic. Started Jun 2006; status: terminated.
02
Drugs
Paclitaxel Micelles for Injectioncarboplatin
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT00568451.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00568451.